New Wave Wealth Advisors LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 370 shares of the medical equipment provider’s stock, valued at approximately $201,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Chilton Capital Management LLC boosted its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical in the first quarter valued at about $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical in the first quarter valued at about $30,000. TD Capital Management LLC boosted its holdings in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical in the first quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Trading Down 2.1%
Shares of Intuitive Surgical stock opened at $438.04 on Thursday. The business’s 50 day simple moving average is $465.33 and its 200-day simple moving average is $500.54. The stock has a market capitalization of $157.03 billion, a price-to-earnings ratio of 61.09, a PEG ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.
Analyst Ratings Changes
A number of brokerages recently commented on ISRG. Wells Fargo & Company increased their price target on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a report on Wednesday, July 23rd. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. BTIG Research reaffirmed a “buy” rating and set a $571.00 target price on shares of Intuitive Surgical in a report on Wednesday. Finally, The Goldman Sachs Group reduced their target price on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a report on Wednesday. Fourteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $594.19.
Read Our Latest Report on ISRG
Insider Transactions at Intuitive Surgical
In other news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- What is a penny stock? A comprehensive guide
- Datavault AI: The New AI Contender Backed by Big Funding
- What is the Nikkei 225 index?
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- The 3 Best Fintech Stocks to Buy Now
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.